GovBidAlerts
OpenSpecial NoticeFederal

SAFE-PLASMA Protocol

Department of Defense · Defense Health Agency (dha)

Due Closes in 4 daysRef. HT9427-27-NOI-701

At a glance

What

The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source…

Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (NAICS 541715)

Who can bid
Any business — no set-aside listed
Where
Frederick, SD
Key dates
  • Posted: Nov 17, 2026
  • Deadline: Mon, Nov 23, 2026 · 1:00 PM CST (closes in 4 days)
How to respond

Jamie Diggs · jamie.l.diggs.civ@health.mil

Submit per the instructions on SAM.gov ↗

Documents
None attached here — check SAM.gov

Description

The Defense Health Agency Contracting Activity, on behalf of Portfolio Acquisition Executive for Medical Products, Warfighter Protection and Acute Care Project Management Office, intends to issue a contract modification on a sole-source basis with Westat Inc. 1600 Research Blvd. Rockville, MD 20850. This modification will enable Westat Inc. to modify the current clinical trial design to comply with FDA recommendations and to conduct the Good Clinical Practices (GCP) compliant clinical trial in accordance with U.S. Food and Drug Administration’s requirements for EZPLAZ™ approval.
All notice detailsShow ↓
Solicitation number
HT9427-27-NOI-701
Notice type
Special Notice
Department
Department of Defense
Sub-agency
Defense Health Agency (dha)
Contracting office
DEFENSE HEALTH AGENCY (DHA)
Place of performance
Frederick, SD
Archive date
Dec 8, 2026
Archive type
auto15
Organization type
AGENCY
Full agency path
DEPT OF DEFENSE.DEFENSE HEALTH AGENCY (DHA).DEFENSE HEALTH AGENCY (DHA)
SAM.gov notice ID
5dbbdec45c0240beb4c3029670b6aa76

Contacts